The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of immune checkpoint inhibitor (ICI) therapy among Veterans Affairs patients with colorectal cancer and discordant dMMR/MSI-H status.
 
James Isaacs
No Relationships to Disclose
 
Aixia Guo
No Relationships to Disclose
 
Vishal Vashistha
Employment - UnitedHealthcare (I)
Research Funding - IBM (Inst)
Other Relationship - IBM
(OPTIONAL) Uncompensated Relationships - IBM
 
Evangelia Katsoulakis
Research Funding - Candel Therapeutics
 
Elizabeth Boswell
No Relationships to Disclose
 
John H Strickler
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Inivata; Mereo Biopharma; Natera (Inst); Pfizer; Pionyr; Roche/Genentech (Inst); Seagen; Silverback Therapeutics; Viatris
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Curegenix (Inst); Daiichi Sankyo/Lilly; Erasca, Inc (Inst); Exelixis (Inst); Leap Therapeutics (Inst); Nektar (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
 
Sara Ahmed
Employment - PierianDx
Leadership - PierianDx
Stock and Other Ownership Interests - PierianDx
 
Michael J. Kelley
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Novartis (Inst); Regeneron (Inst)
Other Relationship - IBM (Inst)